DWA
IBB icon

Dorsey Wright & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Dorsey Wright & Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,032
Closed -$60K – 109
2013
Q2 		$60K Buy
+1,032
New +$59.7K 0.01% 118

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dorsey Wright & Associates's IBB Position: Q3 2013 in Review

Dorsey Wright & Associates sold out of iShares Biotechnology ETF (IBB) in Q3 2013, closing a stake of 1,032 shares — an estimated $60K sold.

Dorsey Wright & Associates first reported a position in IBB in Q2 2013 and held it in 1 quarter. The position peaked at $60K in Q2 2013. 253 funds tracked by Wall St. Rank hold IBB as of Q3 2013.

  • Dorsey Wright & Associates reported no remaining iShares Biotechnology ETF position as of Q3 2013 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,032 iShares Biotechnology ETF shares in Q3 2013, an estimated $60K.
  • Dorsey Wright & Associates first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 1 quarter.
  • Dorsey Wright & Associates's iShares Biotechnology ETF position peaked at $60K in Q2 2013.
  • 253 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2013.

Based on Dorsey Wright & Associates's 13F filing for Q3 2013, filed 23 Oct 2013.